EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study

Rajesh V Swaminathan iD, Guillaume Marquis-Gravel iD, Laurie-Anne Boivin-Proulx iD, Daniel K Benjamin, Aruna Rikhi, Ganesh Raveendran iD, Jeff W Chambers, Arnold H Seto iD, Jayant Bagai iD, Roseann White, Jorge Antonio Gutierrez iD, Thomas J Povsic iD und 2 weitere

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.125.015240 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Rajesh V Swaminathan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Duke Clinical Research Institute, Durham, NC (R.V.S., G.M.-G., J.A.G., T.J.P., M.W.K.). Hauptthemen laut MEDLINE: Fractional Flow Reserve, Myocardial, Adenosine, Coronary Artery Disease, Coronary Stenosis. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Injection of contrast media for rapid measurement of contrast fractional flow reserve (cFFR) obviates the side effects and time requirements of adenosine fractional flow reserve (aFFR) and improves diagnostic performance relative to nonhyperemic pressure ratios. However, studies of cFFR have had variable delivery of contrast. We evaluated the diagnostic performance of cFFR using an automated contrast injector with a standardized volume and rate of delivery of contrast to the reference standard aFFR. METHODS: The ACCELERATION study (Adenosine Contrast Correlations in Evaluating Revascularization) is an investigator-initiated, multicenter, prospective, single-arm trial conducted in 5 sites across the United States. cFFR and aFFR were measured in patients with stable coronary artery disease and intermediate stenosis (40% to 70%) using the ACIST CVi automated contrast injector (iopamidol; left coronary: rate of 4 mL/s, volume of 10 cm 3 and right coronary: rate of 3 mL/s, volume of 6 cm 3 ) and RXi/Navvus FFR microcatheter. The diagnostic performance of cFFR was assessed using a 0.83 cutoff value based on published literature. Optimal cFFR cutoffs were also determined and illustrated using Bland-Altman analysis. RESULTS: A total of 192 lesions from 178 patients were included in the per-protocol analysis (69 with an aFFR ≤0.80 and 109 with an aFFR >0.80). Using a cFFR cutoff value of ≤0.83, the accuracy, sensitivity, and specificity of cFFR were 0.89 (95% CI, 0.83–0.93), 0.70 (95% CI, 0.58–0.81), and 0.99 (95% CI, 0.95–1.00), respectively. The mean difference between cFFR and aFFR was 0.05 (−0.04 to 0.13). A cFFR threshold of ≤0.85 had the highest accuracy in predicting aFFR ≤0.80 with accuracy, sensitivity, and specificity equaling 0.90 (95% CI, 0.84–0.94), 0.87 (95% CI, 0.77–0.94), and 0.91 (95% CI, 0.84–0.95), respectively. CONCLUSIONS: cFFR utilizing standardized parameters for contrast delivery leads to clinically acceptable levels of diagnostic performance compared with traditional aFFR to identify physiologically significant intermediate lesions. Future data evaluating the impact on clinical outcomes of cFFR-guided percutaneous coronary intervention are warranted. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03557385.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fractional Flow Reserve, MyocardialAdenosineCoronary Artery DiseaseCoronary StenosisContrast MediaVasodilator AgentsCoronary AngiographyCardiac CatheterizationHumansProspective StudiesMaleFemaleMiddle AgedAgedPredictive Value of TestsUnited StatesReproducibility of ResultsTime Factors

Stichwörter der Autor:innen

adenosinecontrast mediafractional flow reserve, myocardialiopamidolphysiology

Substanzen

AdenosineContrast MediaVasodilator Agents

Autor:innen und Institutionen

  • Duke Clinical Research Institute, Durham, NC (R.V.S., G.M.-G., J.A.G., T.J.P., M.W.K.).
  • Montreal Heart Institute, Université de Montréal, QC, Canada (G.M.-G.).
  • University of Ottawa Heart Institute, ON, Canada (L.-A.B.-P.).
  • Clemson University, SC (D.K.B.).
  • Parexel International, Durham, NC (A.R.).
  • The University of Minnesota Medical School, Minneapolis (G.R.).

ORCID-Profile: Rajesh V Swaminathan, Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Ganesh Raveendran, Arnold H Seto, Jayant Bagai, Jorge Antonio Gutierrez, Thomas J Povsic, Sunil V Rao

Zitieren

APA

Swaminathan, R. V., Marquis-Gravel, G., Boivin-Proulx, L. A., Benjamin, D. K., Rikhi, A., Raveendran, G., Chambers, J. W., Seto, A. H., Bagai, J., White, R., Gutierrez, J. A., Povsic, T. J., Rao, S. V., & Krucoff, M. W. (2025). Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015240

Vancouver

Swaminathan RV, Marquis-Gravel G, Boivin-Proulx LA, Benjamin DK, Rikhi A, Raveendran G, et al. Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015240

BibTeX
@article{Swaminathan2025,
  author = {Swaminathan, Rajesh V and Marquis-Gravel, Guillaume and Boivin-Proulx, Laurie-Anne and Benjamin, Daniel K and Rikhi, Aruna and Raveendran, Ganesh and Chambers, Jeff W and Seto, Arnold H and Bagai, Jayant and White, Roseann and Gutierrez, Jorge Antonio and Povsic, Thomas J and Rao, Sunil V and Krucoff, Mitchell W},
  title = {Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.125.015240}
}
Kostenlos starten →